Takeda Pharmaceutical Company Limited Reclassification Adjustments On Financial Assets Measured At Fair Value Through Other Comprehensive Income Before Tax
Takeda Pharmaceutical Company Limited (TKPHF) reported Reclassification Adjustments On Financial Assets Measured At Fair Value Through Other Comprehensive Income Before Tax of -JPY 16.36 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeBeforeTax · last filed 2025-06-25
| Period end | Reclassification Adjustments On Financial Assets Measured At Fair Value Through Other Comprehensive Income Before Tax 12 month |
|---|---|
| 2025-03-31 | -16.36B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | -16.15B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -9.12B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 0.00 JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 0.00 JPY 20-F · filed 2023-06-28 |